This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Mark Neil Tolentino, PhD
Senior Scientist at Alnlyam Pharmaceuticals Inc.
Speaker

Profile

I obtained my BS Chemistry degree from University of the Philippines Diliman in 2014. Then, I got my PhD in Chemistry from University of Connecticut in 2021 under the mentorship of Prof. Jessica L. Rouge. My PhD work focused on the development of stimuli-responsive nanoparticles by combining soft and inorganic materials for oligonucleotide and protein delivery applications. My current job at Alnylam involves bioconjugation of oligonucleotides for targeted-delivery applications.

Agenda Sessions

  • Delivering RNAi to Extra-hepatic Tissues

    11:15am